Lab Reagents
All Competitors Laboratories manufactures the ci darlaiani reagents distributed by Genprice. The Ci Darlaiani reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact All Competitors. Other Ci products are available in stock. Specificity: Ci Category: Darlaiani
Serum / Plasma information
CI-1033 (Canertinib) |
E1KS1019 |
EnoGene |
25mg |
EUR 247 |
CI-1040 (PD184352) |
E1KS1020 |
EnoGene |
5mg |
EUR 325 |
CI 966 hydrochloride |
B6677-10 |
ApexBio |
10 mg |
EUR 366 |
CI 966 hydrochloride |
B6677-50 |
ApexBio |
50 mg |
EUR 1379 |
CI 898 trihydrochloride |
B6934-10 |
ApexBio |
10 mg |
EUR 286 |
PD184352 (CI-1040) |
A1792-100 |
ApexBio |
100 mg |
EUR 595 |
Description: PD184352 (also known as CI-1040), a benzhydroxamate derivative, is a potent and highly selective MEK1/2, two members of the family of MAPKKs, inhibitor that inhibits purified MEK1 with IC50 of 17 nM in a non-ATP and non-ERK1/2 competitive manner [1] |
PD184352 (CI-1040) |
A1792-25 |
ApexBio |
25 mg |
EUR 258 |
Description: PD184352 (also known as CI-1040), a benzhydroxamate derivative, is a potent and highly selective MEK1/2, two members of the family of MAPKKs, inhibitor that inhibits purified MEK1 with IC50 of 17 nM in a non-ATP and non-ERK1/2 competitive manner [1] |
PD184352 (CI-1040) |
A1792-5 |
ApexBio |
5 mg |
EUR 108 |
Description: PD184352 (also known as CI-1040), a benzhydroxamate derivative, is a potent and highly selective MEK1/2, two members of the family of MAPKKs, inhibitor that inhibits purified MEK1 with IC50 of 17 nM in a non-ATP and non-ERK1/2 competitive manner [1] |
PD184352 (CI-1040) |
A1792-5.1 |
ApexBio |
10 mM (in 1mL DMSO) |
EUR 113 |
Description: PD184352 (also known as CI-1040), a benzhydroxamate derivative, is a potent and highly selective MEK1/2, two members of the family of MAPKKs, inhibitor that inhibits purified MEK1 with IC50 of 17 nM in a non-ATP and non-ERK1/2 competitive manner [1] |
Canertinib (CI-1033) |
A1845-10 |
ApexBio |
10 mg |
EUR 108 |
Description: Canertinib (also known as CI-1033), a 3-chloro, 4-fluoro, 4-anilinoquinazoline, is an orally available, potent and irreversible Pan-erbB tyrosine kinase inhibitor that inhibits EGFR, HER2 and HER4 in vitro. |
Canertinib (CI-1033) |
A1845-100 |
ApexBio |
100 mg |
EUR 189 |
Description: Canertinib (also known as CI-1033), a 3-chloro, 4-fluoro, 4-anilinoquinazoline, is an orally available, potent and irreversible Pan-erbB tyrosine kinase inhibitor that inhibits EGFR, HER2 and HER4 in vitro. |
Canertinib (CI-1033) |
A1845-5.1 |
ApexBio |
10 mM (in 1mL DMSO) |
EUR 108 |
Description: Canertinib (also known as CI-1033), a 3-chloro, 4-fluoro, 4-anilinoquinazoline, is an orally available, potent and irreversible Pan-erbB tyrosine kinase inhibitor that inhibits EGFR, HER2 and HER4 in vitro. |
Canertinib (CI-1033) |
A1845-50 |
ApexBio |
50 mg |
EUR 148 |
Description: Canertinib (also known as CI-1033), a 3-chloro, 4-fluoro, 4-anilinoquinazoline, is an orally available, potent and irreversible Pan-erbB tyrosine kinase inhibitor that inhibits EGFR, HER2 and HER4 in vitro. |